Merck has collaborated with Palantir to leverage the latter’s advanced data analytics capabilities to help it develop and deliver medicines to patients.
All programs (two promising clinical-stage programs targeting DNA damage and repair, and two novel pre-clinical programs) have first-in-class and best-in-class potential.
Merck KGaA, Darmstadt, Germany, a science and technology company which operates its biopharmaceutical business in the US and Canada as EMD Serono, has entered into a licensing agreement with Vertex Pharmaceuticals Incorporated, Boston, USA, for the